Low-Intensity Regimens for Sickle Cell Disease Transplantation Associated With Risk of Leukemia and MDS

Development and Validation of a Novel TNM Staging N-Classification of Oral Cavity Squamous Cell Carcinoma

Utilizing Biomarkers to Optimize Treatment for Upper Gastrointestinal Cancers

Survival Benefit With Checkpoint Inhibitors Versus Chemotherapy is Modified by Brain Metastases in Patients With Recurrent Small-Cell Lung Cancer

Evaluating Strategies and Approaches to Prevent Graft-Versus-Host Disease

ChatGPT's Limited Ability to Recommend Guideline-Based Cancer Treatments

Response Assessment of Post-Treatment Head and Neck Cancers to Determine Further Management Using NI-RADS (Neck Imaging Reporting and Data System): A Subgroup Analysis of a Randomized Controlled Trial

IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, HER2-, BRCA1/2 Mutant Breast Cancer

Low-Intensity Regimens for Sickle Cell Disease Transplantation Associated With Risk of Leukemia and MDS

header-info

Mar, 13, 2023

According to new study results presented in the Journal of Clinical Oncology, patients with sickle cell disease who underwent low-intensity regimens for transplantations were 2.4% more likely to develop a secondary neoplasm. Researchers analyzed a cohort of 1,096 patients between 1991 and 2016 and calculated 10-year incidence rates based on Fine-Gray regression models.

Access the full article to read more here.